Nicholas Investment Partners, LP - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 122 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$9,926,000
-43.4%
149,425
-33.6%
0.72%
-34.2%
Q2 2021$17,545,000
-15.2%
224,876
+2.8%
1.10%
-23.7%
Q1 2021$20,701,000
-7.5%
218,847
+19.1%
1.44%
-16.5%
Q4 2020$22,381,000
+39.7%
183,676
+0.2%
1.73%
-0.2%
Q3 2020$16,018,000
+690.2%
183,357
+484.3%
1.73%
+321.4%
Q2 2020$2,027,000
-39.9%
31,379
-58.4%
0.41%
-37.4%
Q1 2020$3,371,000
-32.7%
75,487
-6.2%
0.66%
+27.3%
Q4 2019$5,011,000
+25.0%
80,442
-24.5%
0.52%
+53.1%
Q3 2019$4,009,000
-7.8%
106,611
-0.3%
0.34%
-15.5%
Q2 2019$4,350,000106,8900.40%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q4 2019.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders